glp 1 fda compounding Out of Shortage, Into Controversy: The Fight Over GLP-1 FDA restricts non-approved compounded GLP-1

IV therapy can help any patient looking to improve their mental clarity, post-workout recovery, and overall wellness

If you have a Cigna health insurance plan, for example, it may cover Ozempicbut only when its prescribed for Type 2 diabetes since Ozempic isnt FDA approved for weight loss

van Diemen CC, Postma DS, Aulchenko YS, Snijders PJLM, Oostra B, van Duijn CM, Boezen HM: Novel strategy to identify genetic risk factors for COPD severity: a genetic isolate

FDA regulatory context: As of May 2026, the FDA has proposed excluding compounded semaglutide and tirzepatide from the 503B Bulks List, with a public comment period closing June 29, 2026

But they also increase your risk of dehydration especially in the first few weeks of use